151 related articles for article (PubMed ID: 6603242)
1. The immunologic and clinicopathologic heterogeneity of cutaneous lymphomas other than mycosis fungoides.
Wood GS; Burke JS; Horning S; Doggett RS; Levy R; Warnke RA
Blood; 1983 Aug; 62(2):464-72. PubMed ID: 6603242
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides.
Ralfkiaer E; Saati TA; Bosq J; Delsol G; Gatter KC; Mason DY
J Clin Pathol; 1986 May; 39(5):553-63. PubMed ID: 3522633
[TBL] [Abstract][Full Text] [Related]
3. Lymphomatoid papulosis expresses immunophenotypes associated with T cell lymphoma but not inflammation.
Wood GS; Strickler JG; Deneau DG; Egbert B; Warnke RA
J Am Acad Dermatol; 1986 Sep; 15(3):444-58. PubMed ID: 3489740
[TBL] [Abstract][Full Text] [Related]
4. Immunologic phenotypes of diffuse, aggressive, non-Hodgkin's lymphomas. Correlation with clinical features.
Cossman J; Jaffe ES; Fisher RI
Cancer; 1984 Oct; 54(7):1310-7. PubMed ID: 6380700
[TBL] [Abstract][Full Text] [Related]
5. Malignant lymphomas of the skin: their differentiation from lymphoid and nonlymphoid cutaneous infiltrates that simulate lymphoma.
Burke JS
Semin Diagn Pathol; 1985 Aug; 2(3):169-82. PubMed ID: 3916553
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and immunohistological correlation of malignant lymphomas of the skin.
Giam YC; Ong BH
Ann Acad Med Singap; 1994 May; 23(3):412-7. PubMed ID: 7944261
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous lymphomas other than mycosis fungoides: follow-up study of 52 patients.
Joly P; Charlotte F; Leibowitch M; Haioun C; Wechsler J; Dreyfus F; Escande JP; Revuz J; Reyes F; Varet B
J Clin Oncol; 1991 Nov; 9(11):1994-2001. PubMed ID: 1941058
[TBL] [Abstract][Full Text] [Related]
8. Immunopathology of cutaneous T-cell lymphomas.
Nasu K; Said J; Vonderheid E; Olerud J; Sako D; Kadin M
Am J Pathol; 1985 Jun; 119(3):436-47. PubMed ID: 3893149
[TBL] [Abstract][Full Text] [Related]
9. Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas.
Weiss LM; Crabtree GS; Rouse RV; Warnke RA
Am J Pathol; 1985 Feb; 118(2):316-24. PubMed ID: 3155915
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous T cell lymphoma with suppressor/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes.
Agnarsson BA; Vonderheid EC; Kadin ME
J Am Acad Dermatol; 1990 Apr; 22(4):569-77. PubMed ID: 2138636
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
12. CD4+ cutaneous T-cell lymphomas show the phenotype of helper/inducer T cells (CD45RA-, CDw29+).
Sterry W; Mielke V
J Invest Dermatol; 1989 Sep; 93(3):413-6. PubMed ID: 2527911
[TBL] [Abstract][Full Text] [Related]
13. Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor.
Bernard A; Murphy SB; Melvin S; Bowman WP; Caillaud J; Lemerle J; Boumsell L
Blood; 1982 Mar; 59(3):549-54. PubMed ID: 6977384
[TBL] [Abstract][Full Text] [Related]
14. T-cell lymphoma: morphology, immunophenotype and clinical features.
Krajewski AS; Myskow MW; Cachia PG; Salter DM; Sheehan T; Dewar AE
Histopathology; 1988 Jul; 13(1):19-41. PubMed ID: 3061921
[TBL] [Abstract][Full Text] [Related]
15. Peripheral T-cell lymphoma: aggressive disease with heterogeneous immunotypes.
Grogan TM; Fielder K; Rangel C; Jolley CJ; Wirt DP; Hicks MJ; Miller TP; Brooks R; Greenberg B; Jones S
Am J Clin Pathol; 1985 Mar; 83(3):279-88. PubMed ID: 2983525
[TBL] [Abstract][Full Text] [Related]
16. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
Pinkus GS; Said JW
Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
[TBL] [Abstract][Full Text] [Related]
17. Non lymphoblastic T cell lymphomas with prevalent skin involvement different from mycosis fungoides or Sézary's syndrome. A retrospective study of 6 cases in Europe.
Grob JJ; Horchowski N; Tubiana N; Gabriel B; Gastaut JA; Hassoun J; Jouve I; Carcassone Y; Bonerandi JJ
Dermatologica; 1988; 177(2):82-97. PubMed ID: 3262542
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
[TBL] [Abstract][Full Text] [Related]
19. The immunoarchitecture of cutaneous pseudolymphoma.
Wirt DP; Grogan TM; Jolley CS; Rangel CS; Payne CM; Hansen RC; Lynch PJ; Schuchardt M
Hum Pathol; 1985 May; 16(5):492-510. PubMed ID: 3157635
[TBL] [Abstract][Full Text] [Related]
20. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Bosisio FM; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
